GOVX: GeoVax Labs, Inc. Stock

by  •  • Comments Off on GOVX: GeoVax Labs, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 16.56
Enterprise Value ($M) 7.97
Book Value ($M) 8.50
Book Value / Share 0.90
Price / Book 1.95
NCAV ($M) 8.26
NCAV / Share 0.88
Price / NCAV 2.00

Profitability (mra)
Return on Invested Capital (ROIC) -2.86
Return on Assets (ROA) -2.62
Return on Equity (ROE) -4.22

Liquidity (mrq)
Quick Ratio 4.17
Current Ratio 4.17

Balance Sheet (mrq) ($M)
Current Assets 10.87
Assets 11.11
Liabilities 2.61
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Armistice Capital, Llc 9.99 -69.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-11 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 125,364 319,528 39.23
2025-02-03 940,445 2,325,099 40.45
2025-01-31 64,670 189,519 34.12
2025-01-30 56,525 150,596 37.53

(click for more detail)

Similar Companies
GLYC – GlycoMimetics, Inc. GNLX – Genelux Corporation
GNPX – Genprex, Inc. GRCE – Grace Therapeutics, Inc.
GTBP – GT Biopharma, Inc.


Financial data and stock pages provided by
Fintel.io